Immuron IMRN
NASDAQ IMRN
$1.25 +0.01 (+1.21%)
At close: Sep 22, 2026 · 4:00 PM EDT

Immuron (IMRN) Cash & Equivalents Growth (1y) (2016 - 2026)

Analysis

Immuron (IMRN) Cash & Equivalents Growth (1y) (2016 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. Growth (1y) (Qtr)
1 Amgen 212.54 Bn 198.55 Bn 7.24 Bn 74.25%
2 Gilead Sciences 186.84 Bn 183.58 Bn 6.22 Bn -38.20%
3 Vertex Pharmaceuticals 129.39 Bn 121.54 Bn 2.84 Bn 23.56%
4 Regeneron Pharmaceuticals 82.05 Bn 74.06 Bn 3.93 Bn 23.05%
5 Moderna 69.00 Bn 63.87 Bn 52.00 Mn 34.71%
6 Argenx Se 61.15 Bn 55.97 Bn 1.37 Bn 71.81%
7 Alnylam Pharmaceuticals 32.67 Bn 29.37 Bn 992.69 Mn 53.39%
8 Biogen 32.37 Bn 31.08 Bn 1.96 Bn -53.42%
9 Roivant Sciences 28.18 Bn 28.87 Bn 1.16 Mn -
10 Immuron 7.25 Mn -1.77 Mn - 31,759.15%
Historic Data

Historic Data

Download Data
DateValue
Aug 28, 2026 31,759.15%
Dec 31, 2025 -62.87%
Sep 2, 2025 -63.56%
Jun 30, 2025 -76.40%
Dec 31, 2024 -31.76%
Sep 9, 2024 -54.73%
Jun 30, 2024 -33.01%
Dec 31, 2023 -23.10%
Aug 30, 2023 -98.88%
Jun 30, 2023 -27.58%
Dec 31, 2022 -20.77%
Jun 30, 2022 -17.89%
Dec 31, 2021 671.72%
Jun 30, 2021 805.35%
Dec 31, 2020 -32.08%
Jun 30, 2020 -40.60%
Dec 31, 2019 3.14%
Jun 30, 2019 0.21%
Dec 31, 2018 10.39%
Sep 27, 2018 9.81%
API Access

Immuron Cash & Equivalents Growth (1y) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents-growth-1y&ticker=IMRN&period=max&api_key=YOUR_API_KEY